Filter posts

Greenwood Highlights Role of Innovation in Solving Opioid Crisis

The numbers are staggering. The opioid epidemic is costing our nation more than $500 billion annually in …

Hits to Patients Keep on Coming

At a time when prescription drug prices and spending are remarkably stable, patients are getting …

Vaccine Video Series Aims to Educate on the Benefits of Immunization

National Immunization Awareness Month might be coming to a close, but it’s important to continue …

Report: Patients More Likely to Skip Therapy as Out-of-Pocket Costs Rise

IQVIA — a nonpartisan health care research firm — is out with troubling new data …

PBS NewsHour: Why a Patient Paid a $285 Copay for a $40 Drug

A featured story by PBS NewsHour reaffirms that insurance companies and drug cost middlemen determine …

Changes to the Pandemic and All Hazards Preparedness Act Are Essential to Saving Lives in Disasters

Writing for The Hill, Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response for the …

Pfizer CEO: How the Biopharmaceutical Industry Creates Value (And Jobs) for the U.S. Economy

In a recent piece for Forbes, Pfizer’s Chairman and CEO Ian Read highlights the significant …

Greenwood: America Leads in Biopharmaceutical Innovation. Let’s Keep It That Way.

Writing last week for Morning Consult, BIO President and CEO Jim Greenwood proposed several policy …

Insurers and PBMs Limit Access to Safer Opioid Alternatives

Opioid abuse and addiction in America continues to ravish communities, families, and individuals across the …

Co-Pay Accumulator Programs Are a Bad Deal for Patients

As we see time and time again, health insurance providers and pharmacy benefit managers (PBMs) …